Identification of Novel Mycobacterial Inhibitors Against Mycobacterial Protein Kinase G

Protein kinase G (PknG) is a eukaryotic-like serine/threonine kinase that is expressed by Mycobacterium tuberculosis and promotes survival of mycobacteria in host macrophages by suppressing phagosome-lysosome fusion. Thus, compounds showing inhibitory activity against PknG are promising anti-mycobac...

Full description

Bibliographic Details
Main Authors: Yuichi Kanehiro, Haruaki Tomioka, Jean Pieters, Yutaka Tatano, Hyoji Kim, Hisashi Iizasa, Hironori Yoshiyama
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-07-01
Series:Frontiers in Microbiology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fmicb.2018.01517/full
_version_ 1818525956002807808
author Yuichi Kanehiro
Haruaki Tomioka
Jean Pieters
Yutaka Tatano
Hyoji Kim
Hisashi Iizasa
Hironori Yoshiyama
author_facet Yuichi Kanehiro
Haruaki Tomioka
Jean Pieters
Yutaka Tatano
Hyoji Kim
Hisashi Iizasa
Hironori Yoshiyama
author_sort Yuichi Kanehiro
collection DOAJ
description Protein kinase G (PknG) is a eukaryotic-like serine/threonine kinase that is expressed by Mycobacterium tuberculosis and promotes survival of mycobacteria in host macrophages by suppressing phagosome-lysosome fusion. Thus, compounds showing inhibitory activity against PknG are promising anti-mycobacterial agents. We therefore aimed to develop anti-mycobacterial agents by identifying new PknG inhibitors. A luciferase-based PknG kinase assay was used to screen potential inhibitors of PknG. We found that four compounds, namely AZD7762, R406, R406-free base, and CYC116, inhibited PknG activities. AZD7762, R406, and R406-free base promoted transfer of mycobacteria to lysosomes. These compounds also inhibited survival of M. bovis Bacillus Calmette–Guérin (BCG) inside human macrophages. Furthermore, R406 and R406-free base showed bactericidal activity against BCG in infected human macrophages without cytotoxicity. The PknG inhibitors identified in this study by the luciferase-based PknG kinase assay may be promising leads for the development of anti-mycobacterial agents.
first_indexed 2024-12-11T06:16:17Z
format Article
id doaj.art-2e756f4a39154bb3a012ba76f3b98cd0
institution Directory Open Access Journal
issn 1664-302X
language English
last_indexed 2024-12-11T06:16:17Z
publishDate 2018-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Microbiology
spelling doaj.art-2e756f4a39154bb3a012ba76f3b98cd02022-12-22T01:17:58ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2018-07-01910.3389/fmicb.2018.01517333243Identification of Novel Mycobacterial Inhibitors Against Mycobacterial Protein Kinase GYuichi Kanehiro0Haruaki Tomioka1Jean Pieters2Yutaka Tatano3Hyoji Kim4Hisashi Iizasa5Hironori Yoshiyama6Department of Microbiology, Faculty of Medicine, Shimane University, Izumo, JapanDepartment of Basic Medical Sciences for Nursing, Yasuda Women’s University, Hiroshima, JapanBiozentrum, University of Basel, Basel, SwitzerlandDepartment of Pharmaceutical Science, International University of Health and Welfare, Ohtawara, JapanDepartment of Microbiology, Faculty of Medicine, Shimane University, Izumo, JapanDepartment of Microbiology, Faculty of Medicine, Shimane University, Izumo, JapanDepartment of Microbiology, Faculty of Medicine, Shimane University, Izumo, JapanProtein kinase G (PknG) is a eukaryotic-like serine/threonine kinase that is expressed by Mycobacterium tuberculosis and promotes survival of mycobacteria in host macrophages by suppressing phagosome-lysosome fusion. Thus, compounds showing inhibitory activity against PknG are promising anti-mycobacterial agents. We therefore aimed to develop anti-mycobacterial agents by identifying new PknG inhibitors. A luciferase-based PknG kinase assay was used to screen potential inhibitors of PknG. We found that four compounds, namely AZD7762, R406, R406-free base, and CYC116, inhibited PknG activities. AZD7762, R406, and R406-free base promoted transfer of mycobacteria to lysosomes. These compounds also inhibited survival of M. bovis Bacillus Calmette–Guérin (BCG) inside human macrophages. Furthermore, R406 and R406-free base showed bactericidal activity against BCG in infected human macrophages without cytotoxicity. The PknG inhibitors identified in this study by the luciferase-based PknG kinase assay may be promising leads for the development of anti-mycobacterial agents.https://www.frontiersin.org/article/10.3389/fmicb.2018.01517/fulleukaryotic-like serine/threonine kinasePknGmacrophagesphagolysosomeanti-mycobacterialchemotherapy
spellingShingle Yuichi Kanehiro
Haruaki Tomioka
Jean Pieters
Yutaka Tatano
Hyoji Kim
Hisashi Iizasa
Hironori Yoshiyama
Identification of Novel Mycobacterial Inhibitors Against Mycobacterial Protein Kinase G
Frontiers in Microbiology
eukaryotic-like serine/threonine kinase
PknG
macrophages
phagolysosome
anti-mycobacterial
chemotherapy
title Identification of Novel Mycobacterial Inhibitors Against Mycobacterial Protein Kinase G
title_full Identification of Novel Mycobacterial Inhibitors Against Mycobacterial Protein Kinase G
title_fullStr Identification of Novel Mycobacterial Inhibitors Against Mycobacterial Protein Kinase G
title_full_unstemmed Identification of Novel Mycobacterial Inhibitors Against Mycobacterial Protein Kinase G
title_short Identification of Novel Mycobacterial Inhibitors Against Mycobacterial Protein Kinase G
title_sort identification of novel mycobacterial inhibitors against mycobacterial protein kinase g
topic eukaryotic-like serine/threonine kinase
PknG
macrophages
phagolysosome
anti-mycobacterial
chemotherapy
url https://www.frontiersin.org/article/10.3389/fmicb.2018.01517/full
work_keys_str_mv AT yuichikanehiro identificationofnovelmycobacterialinhibitorsagainstmycobacterialproteinkinaseg
AT haruakitomioka identificationofnovelmycobacterialinhibitorsagainstmycobacterialproteinkinaseg
AT jeanpieters identificationofnovelmycobacterialinhibitorsagainstmycobacterialproteinkinaseg
AT yutakatatano identificationofnovelmycobacterialinhibitorsagainstmycobacterialproteinkinaseg
AT hyojikim identificationofnovelmycobacterialinhibitorsagainstmycobacterialproteinkinaseg
AT hisashiiizasa identificationofnovelmycobacterialinhibitorsagainstmycobacterialproteinkinaseg
AT hironoriyoshiyama identificationofnovelmycobacterialinhibitorsagainstmycobacterialproteinkinaseg